Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Deeth Williams Wall LLP

02 9Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

02

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

03

Deeth Williams Wall LLP

arrow
Pharmaconex
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

04

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

05

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

06

Deeth Williams Wall LLP

arrow
Pharmaconex
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

07

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

08

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

09

Deeth Williams Wall LLP

arrow
Pharmaconex
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

10

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Burosumab

Brand Name : CRYSVITA

Patent Number : 2949234

Filing Date : 2015-05-29

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-05-29

Date Granted : 2022-03-22

blank